RMED: Ra Medical Systems, Inc. - Summary | Jitta

Ra Medical Systems, Inc.

NYSE:RMED

Notice
Stock data is unavailable or the company’s delisted.
Price
$4.60
Loss Chance
58.4%
0.48JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (15)
Recent Business Performance (53)
Financial Strength (27)
Return to Shareholders (0)
Competitive Advantage (15)
Jitta Signs
Recent IPOLess than 3 years
Operating MarginDeclined
Recent Business PerformanceEarning decline 84.73% in the last year
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.48
100.00%
3.06
206.98%
Health Care Equipment
7.50
4.33%
5.52
270.75%
5.66
126.23%
COMPANY DESCRIPTION
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.